Faculty Division Aker University Hospital, University of Oslo, Aker, N-0514 Oslo, Norway.
Mol Cancer. 2011 May 6;10:50. doi: 10.1186/1476-4598-10-50.
The pre-leukemia transcription factor 3 (PBX) is part of the PBX family of transcription factors, which is known to regulate genes involved in differentiation of urogenital organs and steroidogenesis. This is of interest with regard to prostate cancer progression as regulation of steroidogenesis is one of the mechanisms involved in the development of castration-resistant prostate cancer. In light of this we wanted to investigate the possible involvement of androgen regulation of PBX3 expression in prostate cancer.
In this study, we show that PBX3 is post-transcriptionally regulated by androgen in prostate cancer cells and that the effect might be independent of the androgen receptor. Furthermore, PBX3 was identified as a target of Let-7d, an androgen regulated microRNA. Let-7d was down-regulated in malignant compared to benign prostate tissue, whereas up-regulation of PBX3 expression was observed.
We demonstrate that PBX3 is up-regulated in prostate cancer and post- transcriptionally regulated by androgen through Let-7d.
白血病前转录因子 3(PBX)是转录因子 PBX 家族的一部分,已知其可调节参与尿生殖器官分化和类固醇生成的基因。这与前列腺癌的进展有关,因为类固醇生成的调节是导致去势抵抗性前列腺癌发生的机制之一。有鉴于此,我们希望研究雄激素对 PBX3 表达的调节是否参与前列腺癌的发生。
在这项研究中,我们表明雄激素可通过转录后调控前列腺癌细胞中的 PBX3,并且这种作用可能独立于雄激素受体。此外,PBX3 被鉴定为雄激素调节的 microRNA Let-7d 的靶标。Let-7d 在恶性前列腺组织中相对于良性前列腺组织下调,而 PBX3 表达上调。
我们证明 PBX3 在前列腺癌中上调,并通过 Let-7d 被雄激素转录后调控。